학술논문
Updated Results of CPX-351 in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
Document Type
Abstract
Author
Senapati, Jayastu ; Almanza, Emmanuel Huante ; Kadia, Tapan M.; Montalban-Bravo, Guillermo; Faderl, Stefan ; Sasaki, Koji; Short, Nicholas; Daver, Naval; DiNardo, Courtney D.; Masarova, Lucia; Ferrajoli, Alessandra; Jabbour, Elias; Borthakur, Gautam; Al Azzawi, Hind ; Konopleva, Marina; Garcia-Manero, Guillermo; Andreeff, Michael; Kantarjian, Hagop; Ravandi, Farhad; Alvarado, Yesid
Source
In Blood 15 November 2022 140 Supplement 1:9050-9053
Subject
Language
ISSN
0006-4971